Publication | Closed Access

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

Hematological MalignancyMarrow TransplantationMedicineMetronomic TherapyHematologyPharmacologyImmunologyHigh DosesIntensive ChemotherapyCell TransplantationMetronomic ChemotherapyOncologyRadiation OncologyPoor-risk MalignanciesTumor MicroenvironmentCancer ResearchHealth Sciences